Position in DYN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$26,167,264
+$8,897,314 QoQ
Shares Held
1,443,313
+63.5% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 87.83548682787448.ToString("F0")%
Shared 0.ToString("F0")%
None 12.16451317212552.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. DYN ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in DYN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,167,264 | 1,443,313 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $17,269,950 | 882,922 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,628,064 | 761,112 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,891,383 | 513,801 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,823,947 | 269,976 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,889,421 | 122,641 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,478,293 | 291,712 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,238,352 | 176,774 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,333,221 | 152,632 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $542,400 | 40,782 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $840,097 | 93,761 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,031,982 | 91,732 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $829,105 | 71,971 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $414,527 | 35,766 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $645,400 | 50,819 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $194,481 | 28,309 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $315,921 | 32,772 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $761,184 | 64,019 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $216,039 | 13,303 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $286,942 | 13,638 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $205,073 | 13,205 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $265,419 | 12,639 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||